Skip to content

LLY

Eli Lilly and Company

Selling, general and administrative, 2025
$11.1B
YoY, 2025
+29.1%
5-year CAGR
+12.6%
10-year CAGR
+5.4%

Selling, general and administrative

Selling, general and administrative by fiscal year

PeriodSG&AYoY
2025$11.1B+29.1%
2024$8.6B+16.1%
2023$7.4B+15.0%
2022$6.4B+0.1%
2021$6.4B+5.1%
2020$6.1B−1.5%
2019$6.2B+4.0%
2018$6.0B−0.1%
2017$6.0B−8.4%
2016$6.5B−0.1%
2015$6.5B−1.3%
2014$6.6B−7.1%
2013$7.1B−5.2%
2012$7.5B−4.6%
2011$7.9B+11.7%
2010$7.1B+2.3%
2009$6.9B+4.0%
2008$6.6B+8.7%
2007$6.1B—